A comprehensive pharmacological survey across heterogeneous patient-derived GBM stem cell models
Richard J. R. Elliott, Peter W. Nagle, Muhammad Furqan, John C. Dawson, Vanessa Smer-Barreto, Diego A. Oyarzún, Aoife McCarthy, Alison F. Munro, Camilla Drake, Gillian M. Morrison, Steven M. Pollard, Michael H. Marand, Daniel V. Ebner, Valerie G. Brunton, Margaret C. Frame, Neil O. Carragher
This study screens a large compound library across patient-derived GBM stem cells to identify effective drugs targeting tumor heterogeneity and presents validated hits for further exploration.
iScience · Apr 27, 2026Peer-reviewedCancer Biology